Alzheimer's Drug Discovery Foundation
Cognito Reports Pivotal Phase 3 Results for Spectris AD, a Non-Invasive, At-Home Approach for Alzheimer's Treatment, Backed by ADDF Investment
Study misses primary endpoint, but prespecified analysis suggests possible benefit in mild Alzheimer's, pointing to a potential role for devices…
